Literature DB >> 2198296

Transient insomnia associated with a 3-hour phase advance of sleep time and treatment with zolpidem.

J K Walsh1, P K Schweitzer, J L Sugerman, M J Muehlbach.   

Abstract

A 3-hour phase advance of sleep time was employed to produce a model of transient insomnia. The degree to which this manipulation was effective varied substantially among young, healthy normal sleepers. Zolpidem, an imidazopyridine hypnotic compound, was effective in reversing the sleep disruption in those individuals displaying transient insomnia in this model.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2198296

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


  15 in total

1.  The effect of vestibular stimulation in a four-hour sleep phase advance model of transient insomnia.

Authors:  Andrew D Krystal; Gary K Zammit; James K Wyatt; Stuart F Quan; Jack D Edinger; David P White; Richard P Chiacchierini; Atul Malhotra
Journal:  J Clin Sleep Med       Date:  2010-08-15       Impact factor: 4.062

2.  A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers.

Authors:  Louise M Paterson; Sue J Wilson; David J Nutt; Peter H Hutson; Magnus Ivarsson
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

3.  Efficacy and tolerability of indiplon in transient insomnia.

Authors:  Russell Rosenberg; Thomas Roth; Martin B Scharf; D Alan Lankford; Robert Farber
Journal:  J Clin Sleep Med       Date:  2007-06-15       Impact factor: 4.062

Review 4.  Polysomnographic effects of hypnotic drugs. A review.

Authors:  L Parrino; M G Terzano
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

5.  A randomized, double-blind, single-dose, placebo-controlled, multicenter, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance.

Authors:  Russell P Rosenberg; Steven G Hull; D Alan Lankford; David W Mayleben; David J Seiden; Sandy A Furey; Shyamalie Jayawardena; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2014-10-15       Impact factor: 4.062

6.  A randomized, double-blind, placebo-controlled, multicenter, 28-day, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance.

Authors:  Sandy A Furey; Steven G Hull; Mark T Leibowitz; Shyamalie Jayawardena; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2014-10-15       Impact factor: 4.062

Review 7.  Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.

Authors:  K J Holm; K L Goa
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

8.  Alterations in cyclic alternating pattern associated with phase advanced sleep are differentially modulated by gaboxadol and zolpidem.

Authors:  Vladimir Svetnik; Raffaele Ferri; Shubhankar Ray; Junshui Ma; James K Walsh; Ellen Snyder; Bjarke Ebert; Steve Deacon
Journal:  Sleep       Date:  2010-11       Impact factor: 5.849

9.  Shift work disorder, depression, and anxiety in the transition to rotating shifts: the role of sleep reactivity.

Authors:  David A Kalmbach; Vivek Pillai; Philip Cheng; J Todd Arnedt; Christopher L Drake
Journal:  Sleep Med       Date:  2015-09-28       Impact factor: 3.492

Review 10.  Pharmacotherapy of insomnia: practice and prospects.

Authors:  J Dingemanse
Journal:  Pharm World Sci       Date:  1995-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.